News Release: Just Financed – Ionis Pharmaceuticals Campus

Capital Markets | Healthcare & Life Sciences

Just Financed

State-of-the-Art Life Sciences Campus 100% Absolute Net Leased to Ionis Pharmaceuticals

Transaction Highlights

Date Closed 10/20/2022

Size 246,699 GSF

Leased 100%

Ionis Pharmaceuticals Campus

CBRE U.S. Healthcare and Life Sciences Capital Markets has arranged acquisition financing for the Ionis Pharmaceuticals Campus (the “Campus”), located in Carlsbad, California.

Working on behalf of the buyer, Oxford Properties, Zack Holderman and James Millon, CBRE New York, secured acquisition financing for the $258MM purchase the state-of-the-art life sciences and corporate headquarters campus. The self-contained 18.4 acre Campus was originally developed for Ionis Pharmaceuticals (“Ionis”) and now consists of approximately 246,000 square feet of prime office, lab, and conference center space. The long-term sale-leaseback is 100% leased to Ionis Pharmaceuticals, a biotechnology company that specializes in discovering and developing RNA-targeted therapeutics.

The campus is one of the largest single-tenant life sciences campuses in San Diego County, the third-largest life science cluster in the nation. Our financing team worked with CBRE’s Matt Carlson, Hunter Rowe, Todd Tydlaska, and Anthony Hayes, who represented IONIS, the Seller, in the transaction.

For more information, or if we can help with your healthcare real estate holdings, please contact us.

For more information, please contact:

Zack Holderman
Senior Vice President
Debt & Structured Finance
+1 858 546 4670

Jesse Greshin
Senior Analyst
Debt & Structured Finance
+1 860 808 4810

Lee Asher
Vice Chairman
Investment Properties
+1 404 504 5965

Jordan Selbiger
First Vice President
Investment Properties
+1 404 923 1259

Trent Jemmett
Senior Director
Investment Properties
+1 858 646 4740

Cole Reethof
Associate Director
Investment Properties
+1 404 504 7864

The full content of this article is only available to paid subscribers. If you are an active subscriber, please log in. To subscribe, please click here: SUBSCRIBE

Existing Users Log In